Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients

Not yet recruiting

• Conditions: Stellate Ganglion; Facial Palsy; Pain Management
• Interventions: Drug: Stellate Ganglion Block

• Registration Number: NCT06742255
• Lead Sponsor: Assiut University

Brief Summary

The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-12
• Study First Submitted: 2024-12-16
• Study First Submitted QC: 2024-12-16
• Last Update Submitted: 2024-12-16
• Study First Posted: 2024-12-19
• Last Update Posted: 2024-12-19
• Study Start: 2024-12-20
• Primary Completion: 2024-12-20
• Study Completion: 2024-12-20

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

• facial nerve palsy patients

Exclusion Criteria

1. light of a recent myocardial infarction.
2. anticoagulant use
3. glucoma
4. lateral nerve palsy
5. emphysema
6. cardiac conduction abnormalities
7. active infection, flu, cold
8. uncontrolled cough
9. Fever
10. Very high blood pressure or if you are on blood thinners.
11. allergic reaction to local anesthetics
12. Primary and secondary coagulopathy.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
stellate ganglion block group	Stellate Ganglion Block	-

Primary Outcome Measures

Name	Time	Method
Primary outcome: Average motor conduction latency in six muscle of the face	6 month

Secondary Outcome Measures

Name	Time	Method
Improved muscle tone	6 months	facial muscles start to regain their strength improvement of muscle tone.